Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
CAPS Rating:
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
RSS Headlines
Fool UK
Recs
http://www.fool.com/investing/general/2012/09/27/5-low-risk-high-reward-biotech-stocks.aspx